ENHO and Alzheimer disease: In a separate clinical investigation [161], plasma levels of adropin were found to be diminished in the AD group and reduced in the MOTS-c (mitochondrial open reading frame of the 12S rRNA-c), acute ischemic stroke, and AD groups compared to the control.